Insiders · TRML

Mark Mcdade

Director at Tourmaline Bio, Inc. (TRML)

Mark Mcdade has filed 11 insider reports with the SEC since April 2022, as director at Tourmaline Bio, Inc. (TRML), insider at Icosavax, Inc. (ICVX) and director at Tourmaline Bio, Inc. (TALS). Mark Mcdade made no open-market purchases or sales in the last 12 months. The latest filing, on October 28, 2025, reports sale back to the company and tender of shares in a change of control at Tourmaline Bio, Inc. (TRML).

Filings
11
Companies
3
Bought on market
$3.55M
Sold on market
None

Companies where Mark Mcdade is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Tourmaline Bio, Inc. logo
TRML
Tourmaline Bio, Inc.
Director0Oct 28, 2025
Icosavax, Inc. logo
ICVX
Icosavax, Inc.
Insider0$300K$7.10Feb 21, 2024
Tourmaline Bio, Inc. logo
TALS
Tourmaline Bio, Inc.
Director518$3.25M$32.50Jan 31, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Also sits on boards with

Officers and directors who share two or more companies with Mark Mcdade.

Compare Mark Mcdade with

Other insiders at the same companies

Questions about Mark Mcdade

What is Mark Mcdade's role at Tourmaline Bio, Inc.?
Mark Mcdade reports to the SEC as director at Tourmaline Bio, Inc. (TRML), according to the latest filing on October 28, 2025. Mark Mcdade has also filed as insider at Icosavax, Inc. (ICVX) and director at Tourmaline Bio, Inc. (TALS).
How many shares does Mark Mcdade own?
After the latest filing that states it, Mark Mcdade directly owned 518 shares of Tourmaline Bio, Inc. (TALS). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Mark Mcdade bought or sold stock recently?
The most recent open-market purchase was on January 29, 2024: bought 100,000 shares of Tourmaline Bio, Inc. (TALS) for $3.25M at an average of $32.50.
How do I get alerts when Mark Mcdade files?
Follow Mark Mcdade on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Mark Mcdade (SEC CIK 0001242126). Totals count each trade once, skipping amendments whose original is on file, from Apr 5, 2022 on. View on SEC EDGAR